Clinical trial

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

NCT03635788

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Standard of Care (SOC) Oral ART Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Oral RPV Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Oral CAB Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention RPV-LA Loading Dose Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CAB-LA Loading Dose Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention RPV-LA Maintenance Dose Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CAB-LA Maintenance Dose Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-03-28

PhasePHASE3

Conditions

HIV Infectionsunresolved

Interventions

Standard of Care (SOC) Oral ARTDRUG

Oral RPVDRUG

Oral CABDRUG

RPV-LA Loading DoseDRUG

CAB-LA Loading DoseDRUG

RPV-LA Maintenance DoseDRUG

CAB-LA Maintenance DoseDRUG

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

ViiV Healthcarecollaborator

Mapped research locations

New YorkNew York, United States3 BostonMassachusetts, United States2 ChicagoIllinois, United States2 Los AngelesCalifornia, United States2 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 NashvilleTennessee, United States1 San FranciscoCalifornia, United States1 SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03635788 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.